Leaflet LEVOFLOXACINA ATB 250mg film-coated tablets


Indicated for: bacterial infections

Substance: levofloxacin (fluoroquinolone antibiotic)

ATC: J01MA12 (Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones)

Levofloxacin is an antibiotic from the fluoroquinolone class, used to treat a wide range of bacterial infections. It is effective against respiratory tract infections (such as pneumonia and acute exacerbations of chronic bronchitis), urinary tract infections, pyelonephritis, skin and soft tissue infections, and certain sinus infections.

This medication works by inhibiting bacterial enzymes essential for DNA replication, leading to the destruction of bacteria. It is important to use levofloxacin only for bacterial infections and not for viral infections, such as the common cold or flu.

Side effects may include nausea, diarrhea, dizziness, headache, or insomnia. In rare cases, more serious reactions can occur, such as tendinitis, tendon rupture, severe allergic reactions, or central nervous system disturbances. It is essential to take the medication as prescribed by a doctor, and patients should avoid excessive sun exposure during treatment, as it may increase skin sensitivity.

General data about LEVOFLOXACINA ATB 250mg

  • Substance: levofloxacin
  • Date of last drug list: 01-05-2026
  • Commercial code: W66212001
  • Concentration: 250mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 10
  • Product type: generic
  • Price: 32.74 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 15903/2025/01
  • Shelf life: 4 years

Pharmaceutical forms available for levofloxacin

Concentrations available for levofloxacin

  • 250mg
  • 250mg/50ml
  • 500mg
  • 500mg/100ml
  • 5mg/ml

Combinations with other substances

Compensation lists for LEVOFLOXACINA ATB 250mg Antibiotice

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

32.74 RON

16.37 RON

16.37 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

32.74 RON

32.74 RON

0.00 RON

NHP 1.B (C2) - Tuberculosis

Price

Copayment

Patient

32.74 RON

32.74 RON

0.00 RON